Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Ösophagitis unter Immunsuppression
Translated title of the contribution
:
Esophagitis during immunosuppression
F. Moosig
*
, W. L. Gross
*
Corresponding author for this work
Clinic of Rheumatology
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Esophagitis during immunosuppression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Immunosuppressive Treatment
100%
Esophagitis
100%
Glucocorticoid
50%
Cytomegalovirus
50%
Drug Megadose
25%
Low Drug Dose
25%
Human Immunodeficiency Virus Infection
25%
Venous Ulcer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Esophagitis
100%
Glucocorticoid
50%
Immunosuppressive Agent
50%
Cytomegalovirus
50%
Ulcer
25%
Acquired Immune Deficiency Syndrome
25%
Prednisolone
25%
Human Immunodeficiency Virus Infection
25%
Immunology and Microbiology
Immunosuppression
100%
Immunosuppressive Therapy
50%
Glucocorticoid
50%
Human Immunodeficiency Virus Infection
25%
Prednisolone
25%
Array Comparative Genomic Hybridization
25%
Drug Megadose
25%
Acquired Immune Deficiency Syndrome
25%